MNs from FUS ALS iPSCs, TDP-43 ALS iPSCs and non-SOD1 FALS were used to ultimately identify a compound named ropinirole (ROPI) as a potential candidate for the ALS treatment [121]. Here, TARDBP is linked to amyotrophic lateral sclerosis.